4/A//SEC Filing
ERICKSON RONALD P 4/A
Accession 0001161697-23-000551
CIK 0001074828other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 8:07 AM ET
Size
19.5 KB
Accession
0001161697-23-000551
Insider Transaction Report
Form 4/AAmended
ERICKSON RONALD P
DirectorCEO
Transactions
- Award
Option to Purchase Common Stock
2023-10-10+4,640,844→ 4,640,844 totalExercise: $0.25From: 2023-10-10Exp: 2028-10-10→ Common Stock (4,640,844 underlying)
Holdings
- 1,000,000
Option to Purchase Common Stock
Exercise: $1.41From: 2022-12-14Exp: 2027-12-14→ Common Stock (1,000,000 underlying) - 1,488,085
Common Stock
- 2,079,332(indirect: .)
Convertible Debenture
Exercise: $0.25From: 2018-01-31Exp: 2024-09-30→ Common Stock (2,079,332 underlying) - 855,000
Warrant to Purchase Common Stock
Exercise: $0.25From: 2018-01-31Exp: 2024-01-30→ Common Stock (855,000 underlying) - 1,039,666(indirect: .)
Warrant to Purchase Common Stock
Exercise: $0.25From: 2018-01-31Exp: 2024-01-30→ Common Stock (1,039,666 underlying) - 2,656,932(indirect: .)
Convertible Debenture
Exercise: $0.25From: 2018-01-31Exp: 2024-09-30→ Common Stock (2,656,932 underlying) - 2,000,000
Warrant to Purchase Common Stock
Exercise: $1.53From: 2020-12-15Exp: 2025-12-15→ Common Stock (2,000,000 underlying) - 3,731,350
Option to Purchase Common Stock
Exercise: $1.53From: 2020-12-15Exp: 2025-12-15→ Common Stock (3,731,350 underlying) - 1,200,000
Option to Purchase Common Stock
Exercise: $1.10From: 2019-11-04Exp: 2024-11-04→ Common Stock (1,200,000 underlying) - 1,000,000
Option to Purchase Common Stock
Exercise: $2.09From: 2021-12-16Exp: 2026-12-16→ Common Stock (1,000,000 underlying)
Footnotes (7)
- [F1]Convertible Debenture for $519,833 that is convertible at $0.25 per share by 09/30/2024.
- [F2]Convertible Debenture for $669,223 that is convertible at $0.25 per share by 09/30/2024.
- [F3]Price subject to adjustment.
- [F4]Held by J3E2A2Z Limited Partnership, an entity affiliated with Ronald P. Erickson.
- [F5]Option shares vested upon the Company's successful listing of its Common Stock on Nasdaq or the New York Stock Exchange (including the NYSE American Market).
- [F6]Milestone-based Option shares vest upon the Company's successful milestone achievements set forth in two Stock Option Agreements dated 12/15/2020.
- [F7]Options vest quarterly over four years. Immediate vesting upon the occurrence of a Change-in-Control.
Documents
Issuer
KNOW LABS, INC.
CIK 0001074828
Entity typeother
Related Parties
1- filerCIK 0001140319
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 8:07 AM ET
- Size
- 19.5 KB